Internal Medicine

The long-term PERFECT observational study follows patients from successful Phase I/IIb of ProtheraCytes for the repair and regeneration of damaged cardiac tissues after severe heart attack.

Researchers used a new molecule to prevent spaceflight-induced bone loss in mice on the International Space Station.

Customizable hydrogels could make taking diabetes and cancer medications as well as other biologics easier for patients.

Researchers injected healthy mitochondria to acutely injured kidneys to make them viable for donation.

Clinical trial insights refine early-stage toxicology evaluations, yielding safer medicines.

Evaluating drug toxicity to development and reproduction is a critical component of drug safety assessment. 

After a heart attack, the damage is permanent — for now. Researchers are testing innovative ways to get the heart to regenerate muscle cells and fix itself.